Authors:
Wenzel, C
Dieckmann, K
Fiebiger, W
Mannhalter, C
Chott, A
Raderer, M
Citation: C. Wenzel et al., CD5 expression in a lymphoma of the mucosa-associated lymphoid tissue (MALT)-type as a marker for early dissemination and aggressive clinical behaviour, LEUK LYMPH, 42(4), 2001, pp. 823
Authors:
Ulrich-Pur, H
Kornek, GV
Fiebiger, W
Gedlicka, C
Raderer, M
Lenauer, A
Depisch, D
Lang, F
Pidlich, J
Scheithauer, W
Citation: H. Ulrich-pur et al., Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapy, ANN ONCOL, 12(9), 2001, pp. 1269-1272
Authors:
Raderer, M
Osterreicher, C
Machold, K
Formanek, M
Fiebiger, W
Penz, M
Dragosics, B
Chott, A
Citation: M. Raderer et al., Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease, ANN ONCOL, 12(7), 2001, pp. 937-939
Authors:
Penz, M
Kornek, GV
Raderer, M
Ulrich-Pur, H
Fiebiger, W
Scheithauer, W
Citation: M. Penz et al., Subcutaneous administration of amifostine: A promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy, ANN ONCOL, 12(3), 2001, pp. 421-422
Authors:
Ulrich-Pur, H
Kornek, GV
Fiebiger, W
Schull, B
Raderer, M
Scheithauer, W
Citation: H. Ulrich-pur et al., Treatment of advanced hepatocellular carcinoma with biweekly high-dose gemcitabine, ONCOL-BASEL, 60(4), 2001, pp. 313-315
Authors:
Raderer, M
Kurtaran, A
Scheithauer, W
Fiebiger, W
Weinlaender, G
Oberhuber, G
Citation: M. Raderer et al., Different response to the long-acting somatostatin analogues lanreotide and octreotide in a patient with a malignant carcinoid, ONCOL-BASEL, 60(2), 2001, pp. 141-145
Authors:
Rederer, M
Fiebiger, W
Wrba, F
Scheithauer, W
Citation: M. Rederer et al., Fatal liver failure after the administration of raltitrexed for cancer chemotherapy - A report of two cases, CANCER, 89(4), 2000, pp. 890-892
Authors:
Hejna, M
Kornek, GV
Raderer, M
Valencak, J
Weinlander, G
Fiebiger, W
Miholic, J
Scheithauer, W
Citation: M. Hejna et al., 5-Methyltetrahydrofolate for biochemical modulation of fluorouracil (FU) in patients with advanced colorectal cancer: A randomized phase I-II study of two different FU administration schedules, ANN ONCOL, 9(12), 1998, pp. 1309-1314